Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in context
Summary: Background: Congenital heart disease (CHD) exhibits a marked male predominance in birth prevalence, yet the genetic mechanisms underlying this sex disparity remain poorly understood. This study investigates the contribution of rare damaging variants on autosomes and the X chromosome to sex...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | EBioMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S235239642500180X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849728207674146816 |
|---|---|
| author | Hairui Sun Xiaoyan Hao Hankui Liu Siyao Zhang Jiancheng Han Ye Zhang Tingting Liu Xian Yang Hairui Wang Jiaqi Fan Yuxuan Guan Ni Peng Jiaoyang Xie Hongmei Xia Xueqin Ji Yan Xu Jianguo Zhang Jianbin Wang Feng Lan Hongjia Zhang Xiaoyan Gu Yihua He |
| author_facet | Hairui Sun Xiaoyan Hao Hankui Liu Siyao Zhang Jiancheng Han Ye Zhang Tingting Liu Xian Yang Hairui Wang Jiaqi Fan Yuxuan Guan Ni Peng Jiaoyang Xie Hongmei Xia Xueqin Ji Yan Xu Jianguo Zhang Jianbin Wang Feng Lan Hongjia Zhang Xiaoyan Gu Yihua He |
| author_sort | Hairui Sun |
| collection | DOAJ |
| description | Summary: Background: Congenital heart disease (CHD) exhibits a marked male predominance in birth prevalence, yet the genetic mechanisms underlying this sex disparity remain poorly understood. This study investigates the contribution of rare damaging variants on autosomes and the X chromosome to sex differences in foetal CHD. Methods: Parents of foetuses with CHD were recruited for the study. Rare damaging variants were identified by analysing whole-exome sequencing data from foetus-parental trios, and their contributions to sex differences were estimated through case–control studies. Functional enrichment analysis was conducted to assess functional differences in genetic variants between sexes. Findings: 820 foetal probands with CHD were recruited, including 487 males and 333 females. We identified a significant enrichment of X-linked rare damaging variants, primarily driven by maternally inherited hemizygous variants (MIHVs) in male probands (OR = 1·84, P < 0·05), which accounted for 7·2% of male cases in our cohort. These variants were not found to be enriched in female probands. Additionally, X-linked rare damaging de novo variants (DNVs) were not enriched in either male or female probands (female probands: 1·8% versus female controls: 0·7%, P = 0·6789; no DNVs observed in males). Gene-level variant burden analysis revealed three X-linked CHD candidate genes: DCX, CACNA1F, and MAP3K15. Autosomal rare variants did not show significant differences in variant burdens between sexes. Notably, male probands showed specific functional enrichments in cilia-related pathways for autosomal recessive variants, as well as in chromatin remodelling and nervous system development pathways for autosomal DNVs. Interpretation: Male and female foetal CHD have significantly different genetic landscapes. The enrichment of X-linked rare damaging MIHVs in males provides a genetic explanation for the higher prevalence of CHD in males. This finding highlights the importance of incorporating sex-stratified approaches in clinical diagnostics and research. Funding: Natural Science Foundation of China and Key research and development project of Hebei Province. |
| format | Article |
| id | doaj-art-e817909916ff46fdadaf68a793ce643d |
| institution | DOAJ |
| issn | 2352-3964 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EBioMedicine |
| spelling | doaj-art-e817909916ff46fdadaf68a793ce643d2025-08-20T03:09:37ZengElsevierEBioMedicine2352-39642025-06-0111610573610.1016/j.ebiom.2025.105736Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in contextHairui Sun0Xiaoyan Hao1Hankui Liu2Siyao Zhang3Jiancheng Han4Ye Zhang5Tingting Liu6Xian Yang7Hairui Wang8Jiaqi Fan9Yuxuan Guan10Ni Peng11Jiaoyang Xie12Hongmei Xia13Xueqin Ji14Yan Xu15Jianguo Zhang16Jianbin Wang17Feng Lan18Hongjia Zhang19Xiaoyan Gu20Yihua He21Maternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, China; Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaBGI-genomics, BGI-Shenzhen, Shenzhen, 518083, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, ChinaDepartment of Ultrasound, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, ChinaDepartment of Ultrasound, Ningxia Women's and Children's Hospital, Beijing University First Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital), Yinchuan, 750004, ChinaRizhao People's Hospital, Shandong, 276827, ChinaBGI-genomics, BGI-Shenzhen, Shenzhen, 518083, ChinaSchool of Life Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, 100084, ChinaBeijing Lab for Cardiovascular Precision Medicine, Capital Medical University, Beijing, 100069, ChinaBeijing Lab for Cardiovascular Precision Medicine, Capital Medical University, Beijing, 100069, ChinaMaternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, China; Beijing Lab for Cardiovascular Precision Medicine, Capital Medical University, Beijing, 100069, China; Corresponding author. Maternal-Fetal Medicine Center in Fetal Heart Disease, Capital Medical University, Beijing Anzhen Hospital, Beijing, 100029, China.Maternal-Fetal Medicine Center in Fetal Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China; Beijing Key Laboratory of Maternal-Fetal Medicine in Fetal Heart Disease, Beijing, 100029, China; Beijing Lab for Cardiovascular Precision Medicine, Capital Medical University, Beijing, 100069, China; Corresponding author. Maternal-Fetal Medicine Center in Fetal Heart Disease, Capital Medical University, Beijing Anzhen Hospital, Beijing, 100029, China.Summary: Background: Congenital heart disease (CHD) exhibits a marked male predominance in birth prevalence, yet the genetic mechanisms underlying this sex disparity remain poorly understood. This study investigates the contribution of rare damaging variants on autosomes and the X chromosome to sex differences in foetal CHD. Methods: Parents of foetuses with CHD were recruited for the study. Rare damaging variants were identified by analysing whole-exome sequencing data from foetus-parental trios, and their contributions to sex differences were estimated through case–control studies. Functional enrichment analysis was conducted to assess functional differences in genetic variants between sexes. Findings: 820 foetal probands with CHD were recruited, including 487 males and 333 females. We identified a significant enrichment of X-linked rare damaging variants, primarily driven by maternally inherited hemizygous variants (MIHVs) in male probands (OR = 1·84, P < 0·05), which accounted for 7·2% of male cases in our cohort. These variants were not found to be enriched in female probands. Additionally, X-linked rare damaging de novo variants (DNVs) were not enriched in either male or female probands (female probands: 1·8% versus female controls: 0·7%, P = 0·6789; no DNVs observed in males). Gene-level variant burden analysis revealed three X-linked CHD candidate genes: DCX, CACNA1F, and MAP3K15. Autosomal rare variants did not show significant differences in variant burdens between sexes. Notably, male probands showed specific functional enrichments in cilia-related pathways for autosomal recessive variants, as well as in chromatin remodelling and nervous system development pathways for autosomal DNVs. Interpretation: Male and female foetal CHD have significantly different genetic landscapes. The enrichment of X-linked rare damaging MIHVs in males provides a genetic explanation for the higher prevalence of CHD in males. This finding highlights the importance of incorporating sex-stratified approaches in clinical diagnostics and research. Funding: Natural Science Foundation of China and Key research and development project of Hebei Province.http://www.sciencedirect.com/science/article/pii/S235239642500180XCongenital heart diseaseSex differencesWhole exome sequencingPediatricPrenatal |
| spellingShingle | Hairui Sun Xiaoyan Hao Hankui Liu Siyao Zhang Jiancheng Han Ye Zhang Tingting Liu Xian Yang Hairui Wang Jiaqi Fan Yuxuan Guan Ni Peng Jiaoyang Xie Hongmei Xia Xueqin Ji Yan Xu Jianguo Zhang Jianbin Wang Feng Lan Hongjia Zhang Xiaoyan Gu Yihua He Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in context EBioMedicine Congenital heart disease Sex differences Whole exome sequencing Pediatric Prenatal |
| title | Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in context |
| title_full | Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in context |
| title_fullStr | Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in context |
| title_full_unstemmed | Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in context |
| title_short | Rare damaging variants in the sex differences of congenital heart disease: an exome sequencing studyResearch in context |
| title_sort | rare damaging variants in the sex differences of congenital heart disease an exome sequencing studyresearch in context |
| topic | Congenital heart disease Sex differences Whole exome sequencing Pediatric Prenatal |
| url | http://www.sciencedirect.com/science/article/pii/S235239642500180X |
| work_keys_str_mv | AT hairuisun raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT xiaoyanhao raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT hankuiliu raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT siyaozhang raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT jianchenghan raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT yezhang raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT tingtingliu raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT xianyang raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT hairuiwang raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT jiaqifan raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT yuxuanguan raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT nipeng raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT jiaoyangxie raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT hongmeixia raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT xueqinji raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT yanxu raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT jianguozhang raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT jianbinwang raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT fenglan raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT hongjiazhang raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT xiaoyangu raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext AT yihuahe raredamagingvariantsinthesexdifferencesofcongenitalheartdiseaseanexomesequencingstudyresearchincontext |